标题
A Current Perspective on Daptomycin for the Clinical Microbiologist
作者
关键词
-
出版物
CLINICAL MICROBIOLOGY REVIEWS
Volume 26, Issue 4, Pages 759-780
出版商
American Society for Microbiology
发表日期
2013-10-04
DOI
10.1128/cmr.00030-13
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- AliaFCodon Deletion Abolishes Daptomycin Bactericidal Activity against Vancomycin-Resistant Enterococcus faecalis
- (2013) Jose M. Munita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EarlyIn VitroandIn VivoDevelopment of High-Level Daptomycin Resistance Is Common in Mitis Group Streptococci after Exposure to Daptomycin
- (2013) Cristina García-de-la-Mària et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus Ceftaroline
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study
- (2013) Kyle P. Murray et al. CLINICAL INFECTIOUS DISEASES
- Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome
- (2013) Theodoros Kelesidis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Implementation of an Antimicrobial Stewardship Pathway with Daptomycin for Optimal Treatment of Methicillin-ResistantStaphylococcus aureusBacteremia
- (2013) Ravina Kullar et al. PHARMACOTHERAPY
- Treatment of Methicillin-Resistant Staphylococcus aureus Infections with a Minimal Inhibitory Concentration of 2 μg/mL to Vancomycin: Old (Trimethoprim/Sulfamethoxazole) versus New (Daptomycin or Linezolid) Agents
- (2012) Michelle L Campbell et al. ANNALS OF PHARMACOTHERAPY
- Mechanisms of daptomycin resistance inStaphylococcus aureus: role of the cell membrane and cell wall
- (2012) Arnold S. Bayer et al. Annals of the New York Academy of Sciences
- Native Valve Endocarditis Caused by Corynebacterium striatum with Heterogeneous High-Level Daptomycin Resistance: Collateral Damage from Daptomycin Therapy?
- (2012) Truc T. Tran et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Whole-Genome Analysis of a Daptomycin-Susceptible Enterococcus faecium Strain and Its Daptomycin-Resistant Variant Arising during Therapy
- (2012) Truc T. Tran et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Concentrations in Valve Tissue and Vegetation in Patients with Bacterial Endocarditis
- (2012) Carlo Tascini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biochemical Characterization of Cardiolipin Synthase Mutations Associated with Daptomycin Resistance in Enterococci
- (2012) Milya Davlieva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis
- (2012) José M. Miró et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity
- (2012) Warren E. Rose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genotypic and Phenotypic Evaluation of the Evolution of High-Level Daptomycin Nonsusceptibility in Vancomycin-Resistant Enterococcus faecium
- (2012) Romney M. Humphries et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
- (2012) Brian J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
- (2012) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Target of Daptomycin Is Absent from Escherichia coli and Other Gram-Negative Pathogens
- (2012) Christopher P. Randall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlation of Cell Membrane Lipid Profiles with Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus
- (2012) N. N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlation between Mutations inliaFSRof Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints
- (2012) Jose M. Munita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Case-Control Study ComparingDe Novoand Daptomycin-Exposed Daptomycin-Nonsusceptible Enterococcus Infections
- (2012) Theodoros Kelesidis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- VraT/YvqF Is Required for Methicillin Resistance and Activation of the VraSR Regulon in Staphylococcus aureus
- (2012) Susan Boyle-Vavra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutual inhibition through hybrid oligomer formation of daptomycin and the semisynthetic lipopeptide antibiotic CB-182,462
- (2012) TianHua Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- In Vitro Susceptibilities and Molecular Analysis of Vancomycin-Intermediate and Vancomycin-Resistant Staphylococcus aureus Isolates
- (2012) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
- (2012) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus
- (2012) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Cardiovascular implantable electronic device endocarditis treated with daptomycin with or without transvenous removal
- (2012) Carlo Tascini et al. HEART & LUNG
- Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy
- (2012) T. T. Ho et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division Proteins
- (2012) J. Pogliano et al. JOURNAL OF BACTERIOLOGY
- False Daptomycin-Nonsusceptible MIC Results by Microscan Panel PC 29 Relative to Etest Results for Staphylococcus aureus and Enterococci: Table 1
- (2012) Elizabeth L. Palavecino et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Daptomycin Etest MICs for methicillin-resistant Staphylococcus aureus vary among different media
- (2012) Hanae Nakashima et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Reduced Susceptibility to Host-Defense Cationic Peptides and Daptomycin Coemerge in Methicillin-Resistant Staphylococcus aureus From Daptomycin-Naive Bacteremic Patients
- (2012) N. N. Mishra et al. JOURNAL OF INFECTIOUS DISEASES
- Daptomycin failure in a neutropenic leukemia patient withstaphylococcous aureusmeningitis
- (2012) Krista A. Wahby et al. LEUKEMIA & LYMPHOMA
- DivIVA affects secretion of virulence-related autolysins in Listeria monocytogenes
- (2012) Sven Halbedel et al. MOLECULAR MICROBIOLOGY
- Purification and Activity Testing of the Full-Length YycFGHI Proteins of Staphylococcus aureus
- (2012) Michael Türck et al. PLoS One
- Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus
- (2012) Anton Y. Peleg et al. PLoS One
- Antibiotic Resistance Is Prevalent in an Isolated Cave Microbiome
- (2012) Kirandeep Bhullar et al. PLoS One
- Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content
- (2012) Nagendra N. Mishra et al. PLoS One
- Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistantStaphylococcus aureus: case report and review of the literature
- (2012) D.T. Levy et al. Transplant Infectious Disease
- Breakthrough Bacteremia and Septic Shock Due to Streptococcus anginosus Resistant to Daptomycin in a Patient Receiving Daptomycin Therapy
- (2011) Federico Palacio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Single-Dose Daptomycin in Patients with Suspected or Confirmed Neurological Infections
- (2011) Ravina Kullar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterizing Vancomycin-Resistant Enterococcus Strains with Various Mechanisms of Daptomycin Resistance Developed in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2011) Molly E. Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Genome Sequencing of an Isogenic Pair of USA800 Clinical Methicillin-Resistant Staphylococcus aureus Isolates Obtained before and after Daptomycin Treatment Failure
- (2011) Susan Boyle-Vavra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Case Report of a Successful Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia and MRSA/Vancomycin-Resistant Enterococcus faecium Cholecystitis by Daptomycin
- (2011) Carlo Tascini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inactivation of the Lipopeptide Antibiotic Daptomycin by Hydrolytic Mechanisms
- (2011) Vanessa M. D'Costa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
- (2011) Nagendra N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Basis for Daptomycin Resistance in Enterococci
- (2011) Kelli L. Palmer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
- (2011) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduction in Membrane Phosphatidylglycerol Content Leads to Daptomycin Resistance in Bacillus subtilis
- (2011) Anna-Barbara Hachmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlation of Daptomycin Resistance in a ClinicalStaphylococcus aureusStrain with Increased Cell Wall Teichoic Acid Production and d-Alanylation
- (2011) Ute Bertsche et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- VraSR Two-Component Regulatory System Contributes tomprF-Mediated Decreased Susceptibility to Daptomycin inIn Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus
- (2011) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oligomerization of daptomycin on membranes
- (2011) Jawad K. Muraih et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Characterization of daptomycin oligomerization with perylene excimer fluorescence: Stoichiometric binding of phosphatidylglycerol triggers oligomer formation
- (2011) Jawad K. Muraih et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Staphylococcus aureus requires cardiolipin for survival under conditions of high salinity
- (2011) Melody Tsai et al. BMC MICROBIOLOGY
- Daptomycin Versus Vancomycin for Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus With a High Vancomycin Minimum Inhibitory Concentration: A Case-Control Study
- (2011) C. L. Moore et al. CLINICAL INFECTIOUS DISEASES
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia
- (2011) Theodoros Kelesidis et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?
- (2011) J. Kehrmann et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus
- (2011) Diixa Patel et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach
- (2011) Adrien Fischer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
- (2011) E. A. King et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure
- (2011) Peter G. Kelley et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of Staphylococcus aureus Cardiolipin Synthases 1 and 2 and Their Contribution to Accumulation of Cardiolipin in Stationary Phase and within Phagocytes
- (2011) T. Koprivnjak et al. JOURNAL OF BACTERIOLOGY
- Determination of Vancomycin and Daptomycin MICs by Different Testing Methods for Methicillin-Resistant Staphylococcus aureus
- (2011) Mark C. Kruzel et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
- (2011) Natasha E. Holmes et al. JOURNAL OF INFECTIOUS DISEASES
- Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids
- (2011) Christoph M. Ernst et al. MOLECULAR MICROBIOLOGY
- Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
- (2011) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-dose Pharmacokinetics and Tolerability of Daptomycin 8 to 10 mg/kg in Children Aged 2 to 6 Years With Suspected or Proved Gram-positive Infections
- (2011) Susan M. Abdel-Rahman et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study
- (2011) Ravina Kullar et al. PHARMACOTHERAPY
- Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
- (2011) Benjamin P. Howden et al. PLoS Pathogens
- Treatment of Meningitis Caused by Vancomycin-Resistant Enterococcus faecium: High-Dose and Combination Daptomycin Therapy
- (2010) Jennifer Le et al. ANNALS OF PHARMACOTHERAPY
- Regulation ofmprFby Antisense RNA Restores Daptomycin Susceptibility to Daptomycin-Resistant Isolates ofStaphylococcus aureus
- (2010) Aileen Rubio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Daptomycin against Bacillus anthracis in a Murine Model of Anthrax Spore Inhalation
- (2010) H. S. Heine et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of Daptomycin Nonsusceptibility with Heterogeneous Vancomycin-Intermediate Resistance and Oxacillin Susceptibility in Methicillin-Resistant Staphylococcus aureus during High-Dose Daptomycin Treatment
- (2010) C.-H. Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the "Seesaw Effect")
- (2010) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lysyl-Phosphatidylglycerol Attenuates Membrane Perturbation Rather than Surface Association of the Cationic Antimicrobial Peptide 6W-RP-1 in a Model Membrane System: Implications for Daptomycin Resistance
- (2010) E. Kilelee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus: Evidence for Multiple Resistance Mechanisms
- (2010) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians
- (2010) T. Kelesidis et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis
- (2010) A. Mary Vilay et al. CRITICAL CARE MEDICINE
- Daptomycin compared to standard therapy for the treatment of native valve endocarditis
- (2010) Zeina Kanafani et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Comparison of daptomycin Etest MICs on Mueller Hinton, IsoSensitest and brain heart infusion agars from Europe against 20 Staphylococcus aureus isolates
- (2010) L. M. Koeth et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Daptomycin in synovial fluid during treatment of methicillin-resistant Staphylococcus aureus septic arthritis
- (2010) N. D. Ritchie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A potential role for daptomycin in enterococcal infections: what is the evidence?
- (2010) R. Canton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin, a Bacterial Lipopeptide Synthesized by a Nonribosomal Machinery
- (2010) Lars Robbel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin
- (2010) A. Hussain et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Daptomycin and Rifampin for the Treatment of Methicillin-Resistant Staphylococcus aureus Septic Pulmonary Emboli in the Absence of Endocarditis
- (2010) Eric O. Gomez et al. Microbial Drug Resistance
- A role for the essential YycG sensor histidine kinase in sensing cell division
- (2010) Tatsuya Fukushima et al. MOLECULAR MICROBIOLOGY
- Presence of Adequate Intravitreal Concentrations of Daptomycin After Systemic Intravenous Administration in a Patient with Endogenous Endophthalmitis
- (2010) Kathleen R Sheridan et al. PHARMACOTHERAPY
- Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen
- (2010) Christy Beneri Infection and Drug Resistance
- Successful Use of Intraperitoneal Daptomycin in the Treatment of Vancomycin-Resistant Enterococcus Peritonitis
- (2009) Sarah C. Huen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Multidrug-Resistant Enterococcus faecium Endocarditis Treated with Combination Tigecycline and High-Dose Daptomycin
- (2009) Amanda C Schutt et al. ANNALS OF PHARMACOTHERAPY
- Nine-Hospital Study Comparing Broth Microdilution and Etest Method Results for Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus
- (2009) H. S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Susceptibility to Daptomycin In Vitro and Activity In Vivo in a Rabbit Model of Aortic Valve Endocarditis
- (2009) H. F. Chambers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy Profiles of Daptomycin for Treatment of Invasive and Noninvasive Pulmonary Infections with Streptococcus pneumoniae
- (2009) S. Henken et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains
- (2009) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Analysis of Factors Affecting Susceptibility of Bacillus subtilis to Daptomycin
- (2009) A.-B. Hachmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006
- (2009) H. S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus
- (2009) N. N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low Plasma Level of Cathelicidin Antimicrobial Peptide (hCAP18) Predicts Increased Infectious Disease Mortality in Patients Undergoing Hemodialysis
- (2009) Adrian F. Gombart et al. CLINICAL INFECTIOUS DISEASES
- Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus
- (2009) Lawrence Friedrich et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Localisation of DivIVA by targeting to negatively curved membranes
- (2009) Rok Lenarcic et al. EMBO JOURNAL
- Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE)
- (2009) B. A. Cunha et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy
- (2009) Fred C. Tenover et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Life-Threatening Infection Caused by Daptomycin-Resistant Corynebacterium jeikeium in a Neutropenic Patient
- (2009) C. Schoen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong
- (2009) Pak-Leung Ho et al. JOURNAL OF INFECTION
- Enhanced Expression ofdltABCDIs Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate ofStaphylococcus aureus
- (2009) Soo‐Jin Yang et al. JOURNAL OF INFECTIOUS DISEASES
- Factors Influencing Time to Vancomycin‐Induced Clearance of Nonendocarditis Methicillin‐ResistantStaphylococcus aureusBacteremia: Role of Platelet Microbicidal Protein Killing andagrGenotypes
- (2009) Pamela A. Moise et al. JOURNAL OF INFECTIOUS DISEASES
- Daptomycin is not active against rapidly growing mycobacteria
- (2009) S. Bastian et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
- (2009) Pamela A Moise et al. LANCET INFECTIOUS DISEASES
- Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study
- (2009) J. T. Kielstein et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients
- (2009) N. N. Salama et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Daptomycin Therapy for Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Case Series of 30 Patients
- (2009) Jason C Gallagher et al. PHARMACOTHERAPY
- Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistantStaphylococcus aureusendocarditis
- (2009) S. Vernadakis et al. Transplant Infectious Disease
- The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion
- (2009) Christoph M. Ernst et al. PLoS Pathogens
- Daptomycin Treatment Failure for Vancomycin-Resistant Enterococcus faecium Infective Endocarditis: Impact of Protein Binding?
- (2008) B. S Schwartz et al. ANNALS OF PHARMACOTHERAPY
- Activity of Daptomycin against Listeria monocytogenes Isolates from Cerebrospinal Fluid
- (2008) L. Spanjaard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus
- (2008) N. Cotroneo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serial Daptomycin Selection Generates Daptomycin-Nonsusceptible Staphylococcus aureus Strains with a Heterogeneous Vancomycin-Intermediate Phenotype
- (2008) I. L. B. d. C. Camargo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lipid-specific binding of the calcium-dependent antibiotic daptomycin leads to changes in lipid polymorphism of model membranes
- (2008) David Jung et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Successful Treatment of Methicillin‐ResistantStaphylococcus aureusMeningitis with Daptomycin
- (2008) Dong Heun Lee et al. CLINICAL INFECTIOUS DISEASES
- Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community‐Acquired Pneumonia
- (2008) Peter E. Pertel et al. CLINICAL INFECTIOUS DISEASES
- High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia
- (2008) M. Sharma et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia due to a linezolid “tolerant” strain
- (2008) Burke A. Cunha et al. HEART & LUNG
- Development of multiple lung abscesses during daptomycin treatment for right-sided endocarditis caused by meticillin-resistant Staphylococcus aureus
- (2008) Chia-Ying Liu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease
- (2008) Chin-Chi Kuo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates
- (2008) S. J. Rehm et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis
- (2008) A. I. Hidron et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate
- (2008) M. H. Murthy et al. JOURNAL OF MEDICAL MICROBIOLOGY
- A sensor histidine kinase co-ordinates cell wall architecture with cell division inBacillus subtilis
- (2008) Tatsuya Fukushima et al. MOLECULAR MICROBIOLOGY
- A novel component of the division-site selection system ofBacillus subtilisand a new mode of action for the division inhibitor MinCD
- (2008) Marc Bramkamp et al. MOLECULAR MICROBIOLOGY
- A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence
- (2008) C.-I Liu et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More